Cancer drug resistance study raises immune red flags

Once a cancer patient's tumors develop resistance to chemotherapy, the prognosis can be poor. However, inhibiting a key gene involved in multidrug resistance, MDR1, has not improved outcomes. A new study offers a reason, revealing unintended downstream effects on immune system cells.

from Latest Science News -- ScienceDaily https://ift.tt/2VKXwIV

Comments

Popular posts from this blog

SpaceX wants to launch 100,000 Starlink satellites to orbit

On this day in space! Oct. 28, 1971: Britain launches its 1st satellite Prospero into space on a Black Arrow rocket